Survey
* Your assessment is very important for improving the workof artificial intelligence, which forms the content of this project
* Your assessment is very important for improving the workof artificial intelligence, which forms the content of this project
RAJIV GANDHI UNIVERSITY OF HEALTH SCIENCES BENGALURU, KARNATAKA PROFORMA FOR REGISTRATION OF SUBJECTS FOR DISSERTATION 1 Name of the candidate and address (in block letters) 2 Name of the Institution 3 Course of the study and subject M.S. OBSTETRICS AND GYNAECOLOGY (3 YEARS DURATION) 4 Date of admission to course 22nd APRIL 2011 5 Title of the topic Dr. SRIPRIYA MOHAN VYDEHI INSTITUTE OF MEDICAL SCIENCES AND RESEARCH CENTRE BANGALORE - 66 VYDEHI INSTITUTE OF MEDICAL SCIENCES AND RESEARCH CENTRE BANGALORE - 66 Comparative study of Papanicolaou Smear and Colposcopy in the evaluation of cervical lesions. 6 Brief resume of the intended work 6.1 Need for the study Cancer cervix continues to be the most common genital cancer encountered in India accounting for 80% of all female genital cancers.[1] More so, in relevance to our set up where the rural population is dominant.The average annual crude and age-standardised incidence rate (ASR) of cancer of the cervix in Bangalore for the period 1992-99 was 18.6 and 28.8 per 100,000 respectively.The average annual crude and age-adjusted death rate for the period were 8.2 and 13.3 per 100,000 respectively, giving a mortality incidence ratio of 0.46.[2] The concept pre-invasive disease of cervix or Cervical intraepithelial neoplasia(CIN) denotes changes that are confined to the cervical epithelial cells. Early detection and treatment of CIN has the potential to improve the outcome of treatment.Invasive cancer of cervix is considered to be a preventable condition, since it is associated with a long pre-invasive stage (CIN), making it amenable to screening and treatment.[3] CIN may be identified by microscopic examination of cervical cells in a cytology smear stained by the Papanicolaou technique. In cytological preparations, individual cell changes are assessed for the diagnosis of CIN and its grading. In contrast, histological examination of whole tissues allows several other features to be examined.[3] Nuclear enlargement with variation in size and shape is a regular feature of all dysplastic cells. Increased intensity of staining (hyperchromasia) is another prominent feature. Irregular chromatin distribution with clumping is always present in dysplastic cells. Mitotic figures and visible nucleoli are uncommon in cytological smears. Abnormal nuclei in superficial or intermediate cells indicate a low-grade CIN, whereas abnormality in nuclei of parabasal and basal cells indicates high-grade CIN. The amount of cytoplasm in relation to the size of the nucleus (nuclear-cytoplasmic ratio) is one of the most important base for assessing the grade of CIN. Increased ratios are associated with more severe degrees of CIN. Final diagnosis of CIN is established by the histopathological examination of a cervical punch biopsy or excision specimen. A judgement of whether or not a cervical tissue specimen reveals CIN, and to what degree, is dependent on the histological features concerned with differentiation, maturation and stratification of cells and nuclear abnormalities. The proportion of the thickness of the epithelium showing mature and differentiated cells is used for grading CIN. More severe degrees of CIN are likely to have a greater proportion of the thickness of epithelium composed of undifferentiated cells, with only a narrow layer of mature, differentiated cells on the surface.[3] 6.2 Review of literature Cancer of the cervix is a major health problem in India, which accounts for 26.1—43.8% of all cancers in Indian women.[3] Therefore, screening and early detection of precancerous lesions is a priority in our country. The Papanicolaou (Pap) smear has been recognized widely as the most effective cancer screening test in history of medicine. Pap smear introduced by George Papanicoloau into clinical practice circa 1940 is the primary screening tool for cervical intraepithelial neoplasia (CIN) and invasive cancer of the uterine cervix. Use of the Pap smear has reduced morbidity and mortality from invasive cancer in various population groups.[4] Recently, the assumed accuracy of the Pap smear, 80 to 95% for detecting CIN and early invasive cancer, has been questioned. Conversely, a false negative rate of the Pap smear has been reported under carefully controlled condition.The simultaneous use of cytological studies and screening colposcopy has been shown to increase cervical cancer detection.[5] Colposcopy means to look into the vagina (ie, colpo means vagina, scope means to look). It was first described by Hans Hinselman of Germany in 1925. It is performed using a colposcope, an optical instrument that supplies magnification (typically 5-25X) and often records photographs. Magnification provided by colposcope is 6-40 times. Blue/green filter is used for visualization of vascular pattern, as they appear dark and visibly contrasted against the surrounding epithelium.The false negative rate was significantly lower for colposcopy (1.92%) as compared to that for the Papanicolau smear (17.98%).[6] Visual inspection with acetic acid (VIA) involves swabbing the cervix with a 5% acetic acid solution prior to visual examination. Due to differences in precancerous cell structure and opacity, abnormal cells temporarily appear white when exposed to this solution. Immediately after VIA, the Lugol’s iodine solution is applied over the cervix, areas of healthy tissues will stain brown (mahagony brown) while areas of abnormal cells would turn white or yellow. In case of immature squamous metaplasia, there will be a partial iodine uptake.[7] The application of iodine or acetic acid highlights the area with abnormalities and enables the clinician to take biopsies in the affected area of the cervical epithelium. 6.3 Objectives of the study 1. To compare the efficacy of PAP Smear and Colposcopy. 2.To critically evaluate the sensitivity and specificity of Colposcopy versus pap smear in the early detection of dysplasias 7 Materials and Methods 7.1 Source of data The study will be conducted on 100 women attending Gynaecology OPD and fitting into the inclusion criteria in the Department of Obstetrics and Gynaecology at Vydehi Institute of Medical Sciences & Research Centre, Bangalore, from January 2012 to December 2012. 7.2 Method of collection of data (including sampling procedure if any) This is a cross sectional study. A pre structured proforma will be used to obtain: 1. Written informed consent and counselling 2. Detailed history 3. Clinical examination 4. Investigations Sample Size:100 women fitting into the inclusion criteria will be selected. INCLUSION CRITERIA: 1. Age : 20-60 years 2. Patients with abnormal symptoms like profuse white discharge, post coital bleeding, intermenstrual bleeding or post menopausal bleeding. 3. Patients with clinically unhealthy cervix diagnosed by speculum examination like, cervical erosion, cervicovaginitis, cervical polyp, condylomas etc. EXCLUSION CRITERIA: 1. Patients with bleeding at the time of examination. 2. Women with frank invasive cancer. 3. Pregnant women. Methodology: Basic steps of examination include: 1. Written informed consent and counselling 2. Detailed history 3. Physical examination 4. Local examination of vulva 5. Speculum examination of cervix and vagina 6. Pap smear – Conventional method using Ayre’s spatula and fixed using 95% Alcohol 7. Colposcopic evaluation 8. Inspection of cervix after application of 5% acetic acid 9.Examination through green filter 10.Staining the cervix with Lugol’s iodine 11.Colposcope directed biopsy using a punch biopsy forceps if indicated. Statistical analysis: Data will be analysed using , Chi square test to analyse the efficacy of PAP smear & colposcopy. Sensitivity and Specificity of PAP smear & colposcopy. 7.3 Does the study require any investigations or interventions to be conducted on patients or other humans or animal? If so, please describe briefly. YES The investigations done in the cases selected for the study are : Colposcopic evalution Pap smear Biopsy 7.4 Has ethical clearance been obtained from your institution in case of 7.3 YES 8 References 1. Padubidri VG, Daftary SN. Shaws Textbook of Gynecol 13th ed page 383384 2. Nandakumar A, Anantha N and Thimmastfiy K. (2001).Cancer Patterns in Bangalore, India 1992-99. Population Based Cancer Registry of Bangalore. Kidwai Memorial Institute of Oncology: Bangalore, India. BJC(2007) 96, 11071111.doi:10.1038/sj.bjc.6603679 www.bjcancer.com Published online 6 March 2007 3.Miller AB, Nazeer S, Fonn S. Report on Consensus Conference on Cervical Cancer Screening and Management. Int J Cancer 2000;86:440–7 4. Cronje HS, Parham GP, Cooreman BF, de Beer A, Divall P and Bam RH: A comparison of four screening methods for cervical neoplasia in a developing country. Am J Obstet Gynecol 188(2): 395-400, 2003. 5.Sankaranarayanan R, Nene BM, Dinshaw K. Early detection of cervical cancer: a summary of completed and on-going studies in India. Salud Publica Mex 2003;45:S399–407 6. Syrjanen K, Naud P, Derchain SM, Roteli-Martins C, Longatto- Filho A: Comparing PAP smear cytology, aided visual inspection (VIA), screening colposcopy, cervicography and HPV testing by HCII (normal and selfsampling) as optional screening tools in Latin America. Experience from the LAMS study. In: Monsonego J(ed.). 5th International Multidisciplinary Congress EUROGIN 2003. Monduzi Editore, Milano pp. 65-73, 2003. 7.Singh V, Sehgal A, Parashari A, Sodhani P, Satyanarayana L. early detection of cervical cancer through acetic acid application: An aided visual inspection. Singapore Med J 2002 Aug; 42(8): 351-4. 9 Signature of the candidate 10 Remarks of the guide: FEASABLE AND RECOMMENDED 11 Name and designation of the guide (in block letters) 11.1 Guide Dr. SHREEDHAR VENKATESH PROFESSOR & HOD DEPARTMENT OF OBSTETRICSAND GYNAECOLOGY VYDEHI INSTITUTE OF MEDICAL SCIENCES AND RESEARCH CENTRE, BANGALORE. 11.2 Signature 11.3 Head of the Department 11.4 Signature 12 12.1 Remarks of the Principal 12.2 Signature Dr. SHREEDHAR VENKATESH PROFESSOR & HOD DEPARTMENT OF OBSTETRICSAND GYNAECOLOGY VYDEHI INSTITUTE OF MEDICAL SCIENCES AND RESEARCH CENTRE, BANGALORE.